Literature DB >> 22896622

Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.

Marcel A Schijf1, Debby Kruijsen, Jacqueline Bastiaans, Frank E J Coenjaerts, Johan Garssen, Grada M van Bleek, Belinda van't Land.   

Abstract

Breast feeding reduces the risk of developing severe respiratory syncytial virus (RSV) infections in infants. In addition to maternal antibodies, other immune-modulating factors in human milk contribute to this protection. Specific dietary prebiotic oligosaccharides, similar to oligosaccharides present in human milk, were evaluated in a C57BL/6 mouse RSV infection model. During primary RSV infection, increased numbers of RSV-specific CD4(+) T cells producing gamma interferon (IFN-γ) were found in the lungs at days 8 to 10 postinfection in mice receiving diet containing short-chain galactooligosacharides, long-chain fructooligosaccharides, and pectin-derived acidic oligosaccharides (termed scGOS/lcFOS/pAOS). In a Th2-skewed formalin-inactivated (FI)-RSV vaccination model, the prebiotic diet reduced RSV-specific Th2 cytokine (interleukin-4 [IL-4], IL-5, and IL-13)-producing CD4(+) T cells in the lung and the magnitude of airway eosinophilia at day 4 and 6 after infection. This was accompanied by a decreased influx of inflammatory dendritic cells (CD11b(+)/CD11c(+)) and increased numbers of IFN-γ-producing CD4(+) and CD8(+) T cells at day 8 after viral challenge. These findings suggest that specific dietary oligosaccharides can influence trafficking and/or effector functions of innate immune, CD4(+), and CD8(+) T cell subsets in the lungs of RSV-infected mice. In our models, scGOS/lcFOS/pAOS had no effect on weight but increased viral clearance in FI-RSV-vaccinated mice 8 days after infection. The increased systemic Th1 responses potentiated by scGOS/lcFOS/pAOS might contribute to an accelerated Th1/Th2 shift of the neonatal immune system, which might favor protective immunity against viral infections with a high attack rate in early infancy, such as RSV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22896622      PMCID: PMC3486291          DOI: 10.1128/JVI.06708-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota.

Authors:  Daisuke Fujiwara; Bo Wei; Laura L Presley; Sarah Brewer; Michael McPherson; Michael A Lewinski; James Borneman; Jonathan Braun
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

2.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa.

Authors:  Carlotta De Filippo; Duccio Cavalieri; Monica Di Paola; Matteo Ramazzotti; Jean Baptiste Poullet; Sebastien Massart; Silvia Collini; Giuseppe Pieraccini; Paolo Lionetti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice.

Authors:  Michaël V Lukens; Erwin A W Claassen; Patricia M A de Graaff; Mariska E A van Dijk; Peter Hoogerhout; Mireille Toebes; Ton N Schumacher; Robbert G van der Most; Jan L L Kimpen; Grada M van Bleek
Journal:  Virology       Date:  2006-05-30       Impact factor: 3.616

4.  Role of the indigenous microbiota in maintaining the virus-specific CD8 memory T cells in the lung of mice infected with murine cytomegalovirus.

Authors:  Kazuo Tanaka; Sadaaki Sawamura; Tadayuki Satoh; Kiyoshi Kobayashi; Satoshi Noda
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

5.  Diverse and potent chemokine production by lung CD11bhigh dendritic cells in homeostasis and in allergic lung inflammation.

Authors:  Steven R Beaty; C Edward Rose; Sun-Sang J Sung
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

6.  Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice.

Authors:  A P Vos; B C van Esch; B Stahl; L M'Rabet; G Folkerts; F P Nijkamp; J Garssen
Journal:  Int Immunopharmacol       Date:  2007-08-17       Impact factor: 4.932

7.  CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.

Authors:  Matthew R Olson; Steven M Varga
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

8.  Immunomodulatory constituents of human milk change in response to infant bronchiolitis.

Authors:  Dani-Louise Bryan; Prue H Hart; Kevin D Forsyth; Robert A Gibson
Journal:  Pediatr Allergy Immunol       Date:  2007-09       Impact factor: 6.377

Review 9.  Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Authors:  Elaine M Castilow; Matthew R Olson; Steven M Varga
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

10.  The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections.

Authors:  Joost J Smit; Dennis M Lindell; Louis Boon; Mirjam Kool; Bart N Lambrecht; Nicholas W Lukacs
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

View more
  16 in total

1.  Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice.

Authors:  Fermín Capitán-Cañadas; Borja Ocón; Carlos José Aranda; Andrea Anzola; María Dolores Suárez; Antonio Zarzuelo; Fermín Sánchez de Medina; Olga Martínez-Augustin
Journal:  Eur J Nutr       Date:  2015-07-08       Impact factor: 5.614

Review 2.  Immune responses in neonates.

Authors:  Saleem Basha; Naveen Surendran; Michael Pichichero
Journal:  Expert Rev Clin Immunol       Date:  2014-08-04       Impact factor: 4.473

3.  Comprehensive expectoration nursing in elderly patients with pulmonary infection and its influence on respiratory function.

Authors:  Xiaofang Wu; He Zhang; Jiayi Chen
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

4.  Alterations in regulatory T cells induced by specific oligosaccharides improve vaccine responsiveness in mice.

Authors:  Marcel A Schijf; Joann Kerperien; Jacqueline Bastiaans; Kirsten Szklany; Jenny Meerding; Gerard Hofman; Louis Boon; Femke van Wijk; Johan Garssen; Belinda Van't Land
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

5.  Effects of orally administered galacto-oligosaccharides on immunological parameters in foals: a pilot study.

Authors:  Johannes Cornelis Vendrig; Luc Edgar Coffeng; Johanna Fink-Gremmels
Journal:  BMC Vet Res       Date:  2014-11-19       Impact factor: 2.741

6.  A multi-strain Synbiotic may reduce viral respiratory infections in asthmatic children: a randomized controlled trial.

Authors:  Hamid Ahanchian; Seyed Ali Jafari; Elham Ansari; Toktam Ganji; Mohammad Ali Kiani; Maryam Khalesi; Tooba Momen; Hamidreza Kianifar
Journal:  Electron Physician       Date:  2016-09-20

Review 7.  Human Milk and Allergic Diseases: An Unsolved Puzzle.

Authors:  Daniel Munblit; Diego G Peroni; Alba Boix-Amorós; Peter S Hsu; Belinda Van't Land; Melvin C L Gay; Anastasia Kolotilina; Chrysanthi Skevaki; Robert J Boyle; Maria Carmen Collado; Johan Garssen; Donna T Geddes; Ralph Nanan; Carolyn Slupsky; Ganesa Wegienka; Anita L Kozyrskyj; John O Warner
Journal:  Nutrients       Date:  2017-08-17       Impact factor: 5.717

Review 8.  Mother's Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity.

Authors:  Kirsty Le Doare; Beth Holder; Aisha Bassett; Pia S Pannaraj
Journal:  Front Immunol       Date:  2018-02-28       Impact factor: 7.561

9.  In vitro evaluation of defined oligosaccharide fractions in an equine model of inflammation.

Authors:  Johannes Cornelis Vendrig; Luc Edgar Coffeng; Johanna Fink-Gremmels
Journal:  BMC Vet Res       Date:  2013-07-22       Impact factor: 2.741

10.  Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.

Authors:  Marcel A Schijf; Michael V Lukens; Debby Kruijsen; Nathalie O P van Uden; Johan Garssen; Frank E J Coenjaerts; Belinda Van't Land; Grada M van Bleek
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.